Trials / Completed
CompletedNCT00795327
Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring
The Canadian Study of the Use of Injectable Poly-L-Lactic Acid Dermal Implant for the Treatment of Hill and Valley Acne Scarring
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary: Evaluate the degree of correction attainable with Poly-L-Lactic Acid(Sculptra) for the correction of hill and valley acne scarring Secondary: Document types and incidence of device adverse events with Poly-L-Lactic Acid(Sculptra) therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sculptra (Poly-L-Lactic Acid Dermal Implant) | Drug Device study |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2008-11-21
- Last updated
- 2019-11-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00795327. Inclusion in this directory is not an endorsement.